Vikki Abrahams
 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (April 2022) |
Vikki Abrahams | |
|---|---|
| Academic background | |
| Education | B.Sc., Immunology, 1996, PhD, Immunology, 2000, University College London |
| Thesis | The role of immunoglobulin receptors in the pathogenesis of rheumatoid arthritis (2000) |
| Academic work | |
| Institutions | Yale University School of Medicine |
Vikki Martyne Abrahams is an English–American reproductive immunologist. She is a full professor of obstetrics, gynecology and reproductive sciences at the Yale School of Medicine. Her research focuses on understanding the role of innate immune toll-like receptor and NOD-like receptor family members in placental and maternal-fetal immune responses.
Early life and education[edit]
Abrahams earned her Bachelor of Science degree and PhD from the University College London.[1]
Career[edit]
Abrahams came to the United States for her postdoctoral work at Dartmouth Medical School and Yale University in the field of reproductive immunology before accepting a faculty position in 2004.[1] In her role as an assistant professor of obstetrics and gynecology, Abrahams co-authored a study which found that there was a specific defence mechanism used by the immune system which was imitated by cancer cells in order to fight off the effects of cancer drugs like paclitaxel.[2] She was later awarded a one-year grant of $73,284 from the Lupus Research Alliance for her project titled "Effect of Antiphospholipid Antibodies on Trophoblast Function in Pregnancy."[3] In 2010, Abrahams continued her research into pregnancy complications using a three-year grant from the American Heart Association to advance her work.[4] She also co-authored another study which uncovered how hormone progesterone act to prevent preterm birth.[5]
Abrahams research focuses on understanding the role of innate immune toll-like receptor and NOD-like receptor family members in placental and maternal-fetal immune responses.[1] In 2014, she was the senior author on a study exploring whether an anti-malaria drug could be used to treat obstetrical antiphospholipid syndrome.[6] Two years later, she was the recipient of the 2016 Novel Research Grant from the Lupus Research Institute to conduct innovative work in lupus.[7] She used this grant to lead a study identifying how the Zika virus infects the placenta.[8]
In 2019, Abrahams was the recipient of the annual American Society for Reproductive Immunology Award as someone "who has made outstanding contributions to the area of reproductive immunology."[9]
References[edit]
- ^ a b c "Vikki Abrahams, PhD". medicine.yale.edu. Retrieved November 17, 2020.
- ^ "New Clues to Drug Resistance in Ovarian Cancer". news.yale.edu. May 24, 2006. Retrieved November 17, 2020.
- ^ "Abrahams receives grant to study women with APS". news.yale.edu. January 14, 2009. Retrieved November 17, 2020.
- ^ "Vikki Abrahams receives AHA grant". news.yale.edu. July 15, 2010. Retrieved November 17, 2020.
- ^ "Yale Researchers May Have Uncovered the Mechanism By Which Progesterone Prevents Preterm Birth". news.yale.edu. February 5, 2010. Retrieved November 17, 2020.
- ^ Peart, Karen (January 21, 2014). "Malaria drug combo could help prevent pregnancy complications in lupus patients". medicine.yale.edu. Retrieved November 17, 2020.
- ^ "Reproductive immunologist Vikki Abrahams awarded novel grant to study lupus". medicine.yale.edu. January 20, 2016. Retrieved November 17, 2020.
- ^ Kashef, Ziba (August 18, 2016). "Yale study identifies how Zika virus infects the placenta". news.yale.edu. Retrieved November 17, 2020.
- ^ "Dr. Vikki Abrahams receives the 2019 American Society for Reproductive Immunology Award". medicine.yale.edu. June 18, 2019. Retrieved November 17, 2020.
External links[edit]
Vikki Abrahams publications indexed by Google Scholar